Interferon alpha-2a and dacarbazine in melanoma
Kirkwood, J.M.; Ernstoff, M.S.; Giuliano, A.; Gams, R.; Robinson, W.A.; Costanzi, J.; Pouillart, P.; Speyer, J.; Grimm, M.; Spiegel, R.
Journal of the National Cancer Institute 82(12): 1062-1063
1990
ISSN/ISBN: 0027-8874 PMID: 2189999 Document Number: 365069
Document emailed within 1 workday
Related Documents
Gershanovich, M.L.; Akimov, M.A. 2004: Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma Voprosy Onkologii 50(2): 179-183Konjević, G.; Jović, V.; Radulović, S.; Jelić, S.; Dzodić, R.; Spuzić, I. 2001: Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha Neoplasma 48(3): 175-181
Proebstle, T.M.; Scheibenbogen, C.; Sterry, W.; Keilholz, U. 1996: A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanoma European Journal of Cancer 32a(9): 1530-1533
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
de Braud, F.; Biganzoli, L.; Bajetta, E.; Colleoni, M.; Zampino, M.G. 1993: Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanoma Tumori 79(3): 187-190
Köpf, J.; Hanson, C.; Delle, U.; Weimarck, A.; Stierner, U. 1996: Action of interferon alpha and beta on four human melanoma cell lines in vitro Anticancer Research 16(2): 791-798
Maral, J.; Steinberg, M.; Weil, M.; Chleq, C.; Khayat, D.; Banzet, P.; Jacquillat, C. 1987: Human recombinant leukocyte interferon alpha-2-A in 22 cases of metastatic malignant melanoma Presse Medicale 16(21): 1031-1034
Johnson, D.M.; Hayat, S.Q.; Burton, G.V. 1999: Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma Journal of Rheumatology 26(4): 1009-1010
Hochster, H.; Levin, M.; Speyer, J.; Dunleavy, S.; Harris, M.; Roses, D.; Golomb, F.; Muggia, F. 1985: Single-dose dacarbazine and dactinomycin in advanced malignant melanoma Cancer Treatment Reports 69(1): 39-42
Popov, I.; Jelić, S.; Kovcin, V. 1995: A pilot study of low dose alpha-2b interferon in metastatic malignant melanoma with predominant subcutaneous metastases Srpski Arhiv Za Celokupno Lekarstvo 123(1-2): 5-7
Legha, S.S. 1997: Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy Seminars in Oncology 24(1 Suppl 4: S39-S43
Garbe, C.; Zouboulis, C.C.; Krüger, S.; Waibel, M.; Kreuser, E.D.; Stadler, R.; Orfanos, C.E. 1992: Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(1): 4-10
Serrone, L.; Zeuli, M.; Sega, F.M.; Cognetti, F. 2000: Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview Journal of Experimental and Clinical Cancer Research: Cr 19(1): 21-34
Stadler, R.; Bratzke, B.; Orfanos, C.E. 1987: Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(8): 453-460
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Keilholz, U.; Scheibenbogen, C.; Stoelben, E.; Saeger, H.D.; Hunstein, W. 1994: Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions European Journal of Cancer 30a(7): 955-958
Gundersen, S.; Hager, B.; Tausjø, J. 1986: Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremity Cancer Treatment Reports 70(8): 1015-1017
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339